Kansas City Cancer Ctr. South — Lenexa, Kansas

Kansas City Cancer Ctr. South is a clinical research site located in Lenexa, Kansas, United States 66214.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Kansas City Cancer Ctr. South has participated in 1 clinical trials.

Therapeutic areas: Non Small Cell Lung Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer Ctr. South?

Kansas City Cancer Ctr. South has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer Ctr. South conducted?

Kansas City Cancer Ctr. South has 1 clinical trials on record. Their work covers Non Small Cell Lung Carcinoma.

Is Kansas City Cancer Ctr. South accredited by Crixeo Health?

Kansas City Cancer Ctr. South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Cancer Ctr. South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.